Anti-HPV Monoclonal antibody, Clone DRX-3/3J0&ECOXKU

Objective. Artificial intelligence (AI) could automatedly detect abnormalities in digital cytological images, however, the effect in cervical cancer screening is inconclusive. We aim to evaluate the performance of AI-assisted cytology for the detection of histologically cervical intraepithelial lesions (CIN) or cancer. Methods. We trained a supervised deep learning algorithm based on 188,542 digital cytological images. Between Mar 13, 2017, and Oct 20, 2018, 2145 referral women from organized screening were enrolled in a multicenter, clinical-based, observational study. Cervical specimen was sampled to generate two liquid-based slides: one random slide was allocated to AI-assisted reading, and the other to manual reading conducted by skilled cytologists from senior hospital and cytology doctors from primary hospitals. HPV testing and colposcopy-directed biopsy was performed, and histological result was regarded as reference. We calculated the relative sensitivity and relative specificity of Al-assisted reading compared to manual reading for CIN2+. This trial was registered, number ChiCTR2000034131. Results. In the referral population, Al-assisted reading detected 92.6% of CIN 2 and 96.1% of CIN 3+, significantly higher than or similar to manual reading. AI-assisted reading had equivalent sensitivity (relative sensitivity 1.01, 95%CI, 0.97-1.05) and higher specificity (relative specificity 1.26, 1.20-1.32) compared to skilled cytologists; whereas higher sensitivity (1.12, 1.05-1.20) and specificity (1.36, 1.25-1.48) compared to cytology doctors. In HPV-positive women, AI-assisted reading improved specificity for CIN1 or less at no expense of reduction of sensitivity compared to manual reading. Conclusions. AI-assisted cytology may contribute to the primary cytology screening or triage. Further studies are needed in general population. (C) 2020 Published by Elsevier Inc.

Author summary Human papillomavirus (HPV) is the primary cause of cervical, anogenital, and oropharyngeal cancers. Despite the significant impact of HPV on human health, there is limited understanding of how this small DNA virus traffics through a host cell to cause infection. This work identifies the role of the cellular factor p120 catenin in routing the virus along a productive entry pathway. Specifically, we propose that p120 targets HPV to the transmembrane protein gamma-secretase, a critical step of viral entry. This work thus provides insights into the intracellular transport mechanisms of HPV and identifies a potential therapeutic target for HPV treatment. During internalization and trafficking, human papillomavirus (HPV) moves from the cell surface to the endosome where the transmembrane protease gamma-secretase promotes insertion of the viral L2 capsid protein into the endosome membrane. Protrusion of L2 through the endosome membrane into the cytosol allows the recruitment of cytosolic host factors that target the virus to the Golgien routefor productive infection. How endosome-localized HPV is delivered to gamma-secretase, a decisive infection step, is unclear. Here we demonstrate that cytosolic p120 catenin, likely via an unidentified transmembrane protein, interacts with HPV at early time-points during viral internalization and trafficking. In the endosome, p120 is not required for low pH-dependent disassembly of the HPV L1 capsid protein from the incoming virion. Rather, p120 is required for HPV to interact with gamma-secretase-an interaction that ensures the virus is transported along a productive route. Our findings clarify an enigmatic HPV infection step and provide critical insights into HPV infection that may lead to new therapeutic strategies against HPV-induced diseases.